Metformin and Rapamycin: A Dual Approach to Longevity and Disease Management

Metformin and Rapamycin: A Dual Approach to Longevity and Disease Management

Metformin and rapamycin are two drugs that have garnered significant attention in recent years for their potential roles in extending lifespan and managing age-related diseases. Originally developed for managing diabetes and preventing organ rejection, respectively,...
Telomere Extension: The Frontier of Longevity and Cellular Health

Telomere Extension: The Frontier of Longevity and Cellular Health

Telomere extension has emerged as a promising and transformative approach in the quest for extending lifespan and improving cellular health. Telomeres, the protective caps at the ends of chromosomes, play a crucial role in cellular aging and function. As we age,...
Senescence-Associated Secretory Phenotype (SASP) Inhibitors: A New Frontier in Aging and Disease

Senescence-Associated Secretory Phenotype (SASP) Inhibitors: A New Frontier in Aging and Disease

n the realm of aging research and regenerative medicine, the Senescence-Associated Secretory Phenotype (SASP) has emerged as a critical player in age-related diseases and chronic inflammation. SASP refers to the inflammatory and pro-fibrotic factors secreted by...

Understanding Senolytic Drugs: The Frontier of Aging Research

In recent years, the field of aging research has made significant strides, shedding light on the biological mechanisms that underpin the aging process and how we might intervene to extend both lifespan and healthspan. Among the most exciting developments are senolytic...
UA-213402459-1